# The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure

> **NCT01580553** · PHASE2,PHASE3 · COMPLETED · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 268 (actual)

## Conditions studied

- Heart Failure,

## Interventions

- **DRUG:** Levocarnitine Injection
- **DRUG:** Levocarnitine placebo

## Key facts

- **NCT ID:** NCT01580553
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 268 (ACTUAL)
- **Last updated:** 2012-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01580553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01580553, "The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01580553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*